{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:15:28Z","timestamp":1791040528345,"version":"4.1.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"The Russian Academic Excellence Project 5-100","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"The Austrian Society of Rheumatology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,16]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>We compared the common pathway components C3a, C5a and membrane attack complex (MAC), also known as C5b-9, and the alternative pathway components factor B and properdin in patients with ANCA-associated vasculitis (AAV) and healthy controls, and conducted a meta-analysis of the available clinical evidence for the role of complement activation in the pathogenesis of AAV. Complement components were evaluated in 59\u00a0patients with newly diagnosed or relapsing granulomatosis with polyangiitis or microscopic polyangiitis and 36 healthy volunteers. In 28 patients, testing was repeated in remission. Next, we performed a meta-analysis by searching databases to identify studies comparing complement levels in AAV patients and controls. A random-effects model was used for statistical analyses. The median concentrations of MAC, C5a, C3a and factor B were higher in active AAV patients (P &amp;lt; 0\u00b7001). Achievement of remission was associated with reductions in C3a (P = 0\u00b7005), C5a (P = 0\u00b7035) and factor B levels (P = 0\u00b7045), whereas MAC and properdin levels did not change. In active AAV, there were no effects of ANCA specificity, disease phenotype, previous immunosuppression or disease severity on complement levels. A total of 1122\u00a0articles were screened, and five studies, including this report, were entered into the meta-analysis. Plasma MAC, C5a and factor B in patients with active AAV were increased compared to patients in remission (excluding factor B) and controls. Changes in C3a were of borderline significance. Our findings and the results of the meta-analysis support activation of the complement system predominantly via the alternative pathway in AAV patients.<\/jats:p>","DOI":"10.1111\/cei.13498","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T10:18:06Z","timestamp":1595326686000},"page":"394-402","source":"Crossref","is-referenced-by-count":67,"title":["The alternative complement pathway in ANCA-associated vasculitis: further evidence and a meta-analysis"],"prefix":"10.1093","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7232-4640","authenticated-orcid":false,"given":"S","family":"Moiseev","sequence":"first","affiliation":[{"name":"Tareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University, Moscow, Russia"},{"name":"Lomonosov Moscow State University, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3932-614X","authenticated-orcid":false,"given":"J M","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Chungnam National University Hospital and College of Medicine, Daejeon, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7674-8643","authenticated-orcid":false,"given":"A","family":"Zykova","sequence":"additional","affiliation":[{"name":"Tareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University, Moscow, Russia"},{"name":"Lomonosov Moscow State University, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3989-2590","authenticated-orcid":false,"given":"N","family":"Bulanov","sequence":"additional","affiliation":[{"name":"Tareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0148-5655","authenticated-orcid":false,"given":"P","family":"Novikov","sequence":"additional","affiliation":[{"name":"Tareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5089-0249","authenticated-orcid":false,"given":"E","family":"Gitel","sequence":"additional","affiliation":[{"name":"Central Laboratory, Sechenov First Moscow State Medical University, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bulanova","sequence":"additional","affiliation":[{"name":"Vladimir Regional Clinical Hospital, Vladimir, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Safonova","sequence":"additional","affiliation":[{"name":"Lomonosov Moscow State University, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2326-1820","authenticated-orcid":false,"given":"J I","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yonsei University College of Medicine, Seoul, South Korea"},{"name":"Division of Pediatric Nephrology, Severance Children's Hospital, Seoul, South Korea"},{"name":"Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2945-2946","authenticated-orcid":false,"given":"A","family":"Kronbichler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D R W","family":"Jayne","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"key":"2021121023213801000_cei13498-bib-0001","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41584-018-0145-y","article-title":"Pathogenesis and therapeutic interventions for ANCA-associated vasculitis","volume":"15","author":"Nakazawa","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"2021121023213801000_cei13498-bib-0002","doi-asserted-by":"crossref","first-page":"e0195680","DOI":"10.1371\/journal.pone.0195680","article-title":"Hypocomplementemia is associated with worse renal survival in ANCA-positive granulomatosis with polyangiitis and microscopic polyangiitis","volume":"13","author":"Deshayes","year":"2018","journal-title":"PLOS ONE"},{"key":"2021121023213801000_cei13498-bib-0003","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrneph.2017.37","article-title":"Complement in ANCA-associated vasculitis: mechanisms and implications for management","volume":"13","author":"Chen","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"2021121023213801000_cei13498-bib-0004","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.molimm.2019.06.018","article-title":"ANCA associated vasculitis: the journey to complement-targeted therapies","volume":"112","author":"Quintana","year":"2019","journal-title":"Mol Immunol"},{"key":"2021121023213801000_cei13498-bib-0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1681\/ASN.2013020143","article-title":"C5a receptor (CD88) blockade protects against MPO-ANCA GN","volume":"25","author":"Xiao","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"2021121023213801000_cei13498-bib-0006","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/ndt\/gfv288","article-title":"Complement in ANCA-associated glomerulonephritis","volume":"32","author":"Hilhorst","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2021121023213801000_cei13498-bib-0007","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1681\/ASN.2008050497","article-title":"C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis","volume":"20","author":"Schreiber","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2021121023213801000_cei13498-bib-0008","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2353\/ajpath.2007.060573","article-title":"Alternative complement pathway in the pathogenesis of disease mediated by antineutrophil cytoplasmic autoantibodies","volume":"170","author":"Xiao","year":"2007","journal-title":"Am J Pathol"},{"key":"2021121023213801000_cei13498-bib-0009","doi-asserted-by":"crossref","first-page":"102424","DOI":"10.1016\/j.autrev.2019.102424","article-title":"Complement alternative pathway in ANCA-associated vasculitis: two decades from bench to bedside","volume":"19","author":"Brilland","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2021121023213801000_cei13498-bib-0010","doi-asserted-by":"crossref","first-page":"R140","DOI":"10.1186\/ar3873","article-title":"C5a and its receptors in human anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis","volume":"14","author":"Yuan","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2021121023213801000_cei13498-bib-0011","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ki.2012.313","article-title":"Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"83","author":"Gou","year":"2013","journal-title":"Kidney Int"},{"key":"2021121023213801000_cei13498-bib-0012","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/ndt\/gfv336","article-title":"Evaluation and validation of biomarkers in granulomatosis with polyangiitis and microscopic polyangiitis","volume":"31","author":"Kronbichler","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"2021121023213801000_cei13498-bib-0013","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3899\/jrheum.181347","article-title":"Microparticles expressing myeloperoxidase and complement C3a and C5a as markers of renal involvement in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"47","author":"Antovic","year":"2020","journal-title":"J Rheumatol"},{"key":"2021121023213801000_cei13498-bib-0014","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2021121023213801000_cei13498-bib-0015","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2021121023213801000_cei13498-bib-0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2021121023213801000_cei13498-bib-0017","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/oxfordjournals.ndt.a027086","article-title":"The renal histopathology in systemic vasculitis: an international survey study of inter- and intra-observer agreement","volume":"11","author":"Bajema","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"2021121023213801000_cei13498-bib-0018","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1681\/ASN.2010050477","article-title":"Histopathologic classification of ANCA-associated glomerulonephritis","volume":"21","author":"Berden","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2021121023213801000_cei13498-bib-0019","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/rheumatology\/kez148","article-title":"Subclassifying ANCA-associated vasculitis: a unifying view of disease spectrum","volume":"58","author":"Mahr","year":"2019","journal-title":"Rheumatology"},{"key":"2021121023213801000_cei13498-bib-0020","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/art.41011","article-title":"Measuring circulating complement activation products in myeloperoxidase- and proteinase 3-antineutrophil cytoplasmic antibody-associated Vasculitis","volume":"71","author":"Wu","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2021121023213801000_cei13498-bib-0021","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cll.2019.07.006","article-title":"Analysis of the complement system in the clinical immunology laboratory","volume":"39","author":"Ling","year":"2019","journal-title":"Clin Lab Med"},{"key":"2021121023213801000_cei13498-bib-0022","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.2215\/CJN.02790313","article-title":"Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN","volume":"8","author":"Gou","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021121023213801000_cei13498-bib-0023","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.nephro.2019.04.001","article-title":"Complement inhibition in ANCA vasculitis","volume":"15","author":"Jayne","year":"2019","journal-title":"Nephrol Ther"},{"key":"2021121023213801000_cei13498-bib-0024","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1681\/ASN.2016111179","article-title":"Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis","volume":"28","author":"Jayne","year":"2017","journal-title":"J Am Soc Nephrol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.13498","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cei.13498","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cei.13498","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/202\/3\/394\/41636012\/cei13498.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/202\/3\/394\/41636012\/cei13498.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:25:06Z","timestamp":1641054306000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/202\/3\/394\/6403194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,9,15]]},"published-print":{"date-parts":[[2020,11,16]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.13498","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,9,15]]}}}